Multiple surface antigen mutations in five blood donors with occult hepatitis B virus infection

Journal of Medical Virology

Volumn 80, Issue 8, 2008, Pages 1344-1349

  Zaaijer, H L ^a,b   Torres, P ^c   Ontanon A ^d   Gonzalez Ponte L ^d   Koppelman, M H G M ^a   Lelie, P N ^e   Van Hemert, F J ^b   Boot, H J ^f  

^a CENTRAL LABORATORY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Grupo de Intervencion en Drogas de la Sociedad Espanola de Medicina Familiar Y Comunitaria   (Spain)

^d Centro de Farmacovigilancia de Cantabria   (Spain)

^e Chiron Blood Testing   (France)

^f NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

DNA; HBsAg; HBV; Mutation; Occult

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; MEMBRANE ANTIGEN;

ADULT; ARTICLE; BLOOD DONOR; FEMALE; GENE CLUSTER; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; STRUCTURAL GENE; VIRUS INFECTION; VIRUS STRAIN;

ADULT; AGED; AMINO ACID SEQUENCE; BLOOD DONORS; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; SEQUENCE ANALYSIS, DNA;

HEPATITIS B VIRUS;

EID: 46049104879     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21233     Document Type: Article

References (25)

1. Allain JP. 2004. Occult hepatitis B virus infection: Implications in transfusion. Vox Sang 86:83-91.
2. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. 1997. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 25:3389-3402.
3. Bartholomeusz A, Schaefer S. 2004. Hepatitis B virus genotypes: Comparison of genotyping methods. Rev Med Virol 14:3-16.
4. Boot HJ, Cremer J, van Ballegooijen WM, Koedijk F, op de Coul E. 2008. Improved tracing of hepatitis B virus transmission chains by phylogenetic analysis based on C region sequences. J Med Virol 80:233-241.
5. Carman WF, Zanetti AR, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ, Thomas HC. 1990. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329.
6. Carman WF, Owsianka A, Wallace LA, Dow BC, Mutimer DJ. 1999. Antigenic characterisation of pre- and post-liver transplant hepatitis B surface antigen sequences from patients treated with hyperimmunoglobulin. J Hepatol 31:195-201.
7. Castro E, Torres P, Gonzales R, Ontanon A, Gonzalez Ponte L, Sedeno M, Echevarria JM, Koppelman M, Zaaijer H, Hernandez JM, Lelie N. 2006. Acute phase and occult HBV infections with muliple mutations in the surface antigen 'a' determinant detected by HBV/HCV/HIV-1 TMA screening of Spanish blood donors. Vox Sang 91:77-78.
8. Cooreman MP, Leroux-Roels G, Paulij WP. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8:237-247.
9. Gerlich WH, Wagner FF, Chudy M, Harritshoj LM, Lattermann A, Wienzek S, Glebe D, Saniewski M, Schüttler CG, Wend UC, Willems WR, Bauerfeind U, Jork C, Bein G, Platz P, Ullum H, Dickmeiss E. 2007. HBsAg non-reactive HBV infection in blood donors: Transmission and pathogenicity. J Med Virol 79:S32-S36.
10. Hall TA. 1999. BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95-98.
11. Hsu HY, Chang MH, Liaw SH, Ni YH, Chen HL. 1999. Changes of hepatitis B surface antigen variants in carrier children before and after universal vaccination in Taiwan. Hepatology 30:1312-1317.
12. Ireland JH, O'Donnell B, Basuni AA, Kean JD, Wallace LA, Lau GKK, Carman WF. 2000. Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology 31:1176-1182.
13. Jeantet D, Chemin I, Mandrand B, Zoulim F, Trepo C, Kay A. 2002. Characterization of two hepatitis B virus populations isolated from a hepatitis B surface antigen-negative patient. Hepatology 35:1215-1224.
14. Kumar S, Tamura K, Nei M. 2004. MEG A3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5:150-163.
15. Lada O, Agut H, Poynard T, Thibault V. 2004. Variability of hepatitis B virus surface antigen in chronic hepatitis B virus carriers who present both HBsAg and anti-HBs antibody. 55th Annual Meeting of the American Association for the Study of Liver Diseases; poster 231. Boston, USA.
16. Lee SY, Choi MS, Lee D, Lee JH, Koh KC, Paik SW, Yoo BC. 2005. Overlapping gene mutations of hepatitis B virus in a chronic hepatitis b patient with hepatitis B surface antigen loss during lamivudine therapy. J Korean Med Sci 20:433-437.
17. Lu M, Lorentz T. 2003. De novo infection in a renal transplant recipient caused by novel mutant of hepatitis B virus despite the presence of protective anti-hepatitis B surface antibody. J Inf Dis 187:1323-1326.
18. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Férey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. 2006. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 44:2321-2326.
19. Raimondo G, Pollicino T, Cacciola I, Squadrito G. 2007. Occult hepatitis B virus infection. J Hepatol 46:160-170.
20. van Steenbergen JE, Niesters HGM, Op de Coul ELM, van Doornum GJJ, Osterhaus ADME, Leentvaar-Kuijpers A, Coutinho RA, van den Hoek JAR. 2002. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol 66:159-165.
21. Wallace LA, Echevarria JE, Echevarria JM, Carman WF. 1994. Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis 170:1300-1303.
22. Weinberger KM, Bauer T, Bohm S, Jilg W. 2000. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol 81:1165-1174.
23. Werle-Lapostolle B, Bowden S, Locarnini S, Wursthorn K, Petersen J, Lau G, Trepo C, Marcellin P, Goodman Z, Delaney WE IV, Xiong S, Brosgart CL, Chen SS, Gibbs CS, Zoulim F. 2004. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 126:1750-1758.
24. Westhoff TH, Jochimsen F, Schmittel A, Stoffler-Meilicke M, Schafer JH, Zidek W, Gerlich WH, Thiel E. 2003. Fatal hepatitis B virus reactivation by an escape mutant following rituximab therapy. Blood 102:1930.
25. Zaaijer HL, van Hemert FJ, Koppelman MH, Lukashov VV. 2007. Independent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol 88:2137-2143.